$2.86 Billion is the total value of Avidity Partners Management LP's 93 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 60.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BDX | Buy | BECTON DICKINSON & CO | $105,089,181 | +47.4% | 398,050 | +38.2% | 3.67% | +55.1% |
| KRTX | Buy | KARUNA THERAPEUTICS INC | $95,891,070 | +30.7% | 442,200 | +9.5% | 3.35% | +37.5% |
| JAZZ | Buy | JAZZ PHARMACEUTICALS PLC | $87,123,389 | -12.2% | 702,778 | +3.7% | 3.04% | -7.6% |
| New | GE HEALTHCARE TECHNOLOGIES I | $84,928,296 | – | 1,045,400 | +100.0% | 2.97% | – | |
| THC | Sell | TENET HEALTHCARE CORP | $80,606,890 | -7.8% | 990,500 | -32.7% | 2.82% | -3.0% |
| ARGX | Sell | ARGENX SEsponsored adr | $71,827,239 | -31.3% | 184,300 | -34.3% | 2.51% | -27.7% |
| IDYA | Sell | IDEAYA BIOSCIENCES INC | $70,163,950 | +39.1% | 2,985,700 | -18.7% | 2.45% | +46.4% |
| SGRY | Sell | SURGERY PARTNERS INC | $69,959,450 | -39.5% | 1,555,000 | -53.7% | 2.44% | -36.4% |
| ABBV | New | ABBVIE INC | $69,844,032 | – | 518,400 | +100.0% | 2.44% | – |
| ARVN | Sell | ARVINAS INC | $68,830,551 | -41.1% | 2,773,189 | -35.1% | 2.40% | -38.0% |
| ZNTL | Sell | ZENTALIS PHARMACEUTICALS INC | $65,842,140 | +30.7% | 2,334,000 | -20.3% | 2.30% | +37.6% |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $62,739,299 | -24.0% | 665,316 | -18.4% | 2.19% | -20.1% |
| LLY | New | LILLY ELI & CO | $62,374,340 | – | 133,000 | +100.0% | 2.18% | – |
| SNDX | Sell | SYNDAX PHARMACEUTICALS INC | $60,110,960 | -26.4% | 2,872,000 | -25.7% | 2.10% | -22.5% |
| UHS | Sell | UNIVERSAL HLTH SVCS INCcl b | $58,390,677 | -31.4% | 370,100 | -44.8% | 2.04% | -27.9% |
| BIO | Sell | BIO RAD LABS INCcl a | $57,853,712 | -45.5% | 152,600 | -31.1% | 2.02% | -42.6% |
| ABC | Buy | AMERISOURCEBERGEN CORP | $57,729,000 | +184.8% | 300,000 | +137.0% | 2.02% | +199.6% |
| PACB | Buy | PACIFIC BIOSCIENCES CALIF IN | $57,687,420 | +30.7% | 4,337,400 | +13.8% | 2.02% | +37.5% |
| LEGN | Sell | LEGEND BIOTECH CORPsponsored ads | $55,148,067 | +2.1% | 798,900 | -28.7% | 1.93% | +7.4% |
| BIIB | Buy | BIOGEN INC | $49,563,900 | +38.4% | 174,000 | +35.1% | 1.73% | +45.6% |
| AKRO | Sell | AKERO THERAPEUTICS INC | $47,857,250 | -48.9% | 1,025,000 | -58.1% | 1.67% | -46.2% |
| CVAC | Buy | CUREVAC N V | $44,806,000 | +81.1% | 4,300,000 | +21.1% | 1.56% | +90.6% |
| ACHC | Sell | ACADIA HEALTHCARE COMPANY IN | $43,802,000 | -48.0% | 550,000 | -52.8% | 1.53% | -45.3% |
| PCVX | Buy | VAXCYTE INC | $43,697,500 | +128.6% | 875,000 | +71.6% | 1.53% | +140.7% |
| MCK | New | MCKESSON CORP | $43,243,772 | – | 101,200 | +100.0% | 1.51% | – |
| APLS | New | APELLIS PHARMACEUTICALS INC | $42,698,570 | – | 468,700 | +100.0% | 1.49% | – |
| BSX | Sell | BOSTON SCIENTIFIC CORP | $42,498,513 | -0.1% | 785,700 | -7.6% | 1.48% | +5.1% |
| RARE | Sell | ULTRAGENYX PHARMACEUTICAL IN | $41,549,291 | -51.3% | 900,700 | -57.7% | 1.45% | -48.7% |
| PFE | New | PFIZER INC | $40,988,690 | – | 1,117,467 | +100.0% | 1.43% | – |
| IMVT | Buy | IMMUNOVANT INC | $39,552,450 | +144.5% | 2,085,000 | +99.9% | 1.38% | +157.2% |
| AXSM | Sell | AXSOME THERAPEUTICS INC | $39,163,700 | +2.5% | 545,000 | -12.0% | 1.37% | +7.9% |
| IMGN | New | IMMUNOGEN INC | $37,698,486 | – | 1,997,800 | +100.0% | 1.32% | – |
| ZTS | Sell | ZOETIS INCcl a | $37,369,570 | -44.9% | 217,000 | -46.7% | 1.30% | -42.0% |
| PRTA | Sell | PROTHENA CORP PLC | $36,529,800 | -29.4% | 535,000 | -49.9% | 1.28% | -25.8% |
| VIR | Sell | VIR BIOTECHNOLOGY INC | $34,955,250 | -8.4% | 1,425,000 | -13.1% | 1.22% | -3.6% |
| IMCR | Sell | IMMUNOCORE HLDGS PLCads | $34,477,000 | -9.4% | 575,000 | -25.3% | 1.20% | -4.7% |
| SRPT | Sell | SAREPTA THERAPEUTICS INC | $34,069,700 | -40.6% | 297,500 | -28.5% | 1.19% | -37.5% |
| ARWR | Sell | ARROWHEAD PHARMACEUTICALS IN | $32,985,500 | -25.4% | 925,000 | -46.9% | 1.15% | -21.5% |
| Sell | BIOHAVEN LTD | $31,694,000 | +56.0% | 1,325,000 | -10.9% | 1.11% | +64.2% | |
| RVMD | Sell | REVOLUTION MEDICINES INC | $28,756,250 | -1.3% | 1,075,000 | -20.1% | 1.00% | +3.8% |
| PRVA | New | PRIVIA HEALTH GROUP INC | $28,193,735 | – | 1,079,806 | +100.0% | 0.98% | – |
| PHAT | Sell | PHATHOM PHARMACEUTICALS INC | $27,919,704 | +90.9% | 1,949,700 | -4.8% | 0.98% | +100.6% |
| BAX | New | BAXTER INTL INC | $27,550,132 | – | 604,700 | +100.0% | 0.96% | – |
| FUSN | FUSION PHARMACEUTICALS INC | $26,619,000 | +23.9% | 5,700,000 | 0.0% | 0.93% | +30.4% | |
| RCKT | Buy | ROCKET PHARMACEUTICALS INC | $26,347,620 | +23.6% | 1,326,000 | +6.6% | 0.92% | +29.9% |
| BPMC | New | BLUEPRINT MEDICINES CORP | $26,228,000 | – | 415,000 | +100.0% | 0.92% | – |
| EDIT | New | EDITAS MEDICINE INC | $24,690,000 | – | 3,000,000 | +100.0% | 0.86% | – |
| Sell | VENTYX BIOSCIENCES INC | $22,714,000 | -64.6% | 692,500 | -63.9% | 0.79% | -62.8% | |
| NTRA | Buy | NATERA INC | $21,064,914 | +51.8% | 432,900 | +73.2% | 0.74% | +59.7% |
| LNTH | New | LANTHEUS HLDGS INC | $20,568,792 | – | 245,100 | +100.0% | 0.72% | – |
| New | MOONLAKE IMMUNOTHERAPEUTICSclass a ord | $20,400,000 | – | 400,000 | +100.0% | 0.71% | – | |
| VRNA | Buy | VERONA PHARMA PLCsponsored ads | $20,178,130 | +14.3% | 954,500 | +8.6% | 0.70% | +20.3% |
| Buy | AMYLYX PHARMACEUTICALS INC | $19,443,198 | -26.4% | 901,400 | +0.2% | 0.68% | -22.6% | |
| AXNX | New | AXONICS INC | $19,163,459 | – | 379,700 | +100.0% | 0.67% | – |
| XENE | New | XENON PHARMACEUTICALS INC | $18,530,050 | – | 481,300 | +100.0% | 0.65% | – |
| REGN | Sell | REGENERON PHARMACEUTICALS | $17,819,792 | -81.8% | 24,800 | -79.2% | 0.62% | -80.8% |
| New | ROIVANT SCIENCES LTD | $17,010,000 | – | 1,687,500 | +100.0% | 0.59% | – | |
| PLRX | Sell | PLIANT THERAPEUTICS INC | $16,608,792 | -76.6% | 916,600 | -65.6% | 0.58% | -75.4% |
| VERV | Sell | VERVE THERAPEUTICS INC | $16,473,750 | -15.5% | 878,600 | -35.0% | 0.58% | -11.1% |
| NTLA | Sell | INTELLIA THERAPEUTICS INC | $16,142,967 | +3.9% | 395,855 | -5.1% | 0.56% | +9.3% |
| CERE | New | CEREVEL THERAPEUTICS HLDNG I | $15,933,148 | – | 501,200 | +100.0% | 0.56% | – |
| New | ACELYRIN INC | $15,675,000 | – | 750,000 | +100.0% | 0.55% | – | |
| PNT | Sell | POINT BIOPHARMA GLOBAL INC | $15,146,508 | -13.6% | 1,671,800 | -30.7% | 0.53% | -9.1% |
| KPTI | Sell | KARYOPHARM THERAPEUTICS INC | $14,982,479 | -60.0% | 8,370,100 | -13.1% | 0.52% | -58.0% |
| KZR | Sell | KEZAR LIFE SCIENCES INC | $14,896,000 | -27.0% | 6,080,000 | -6.7% | 0.52% | -23.2% |
| SDGR | New | SCHRODINGER INC | $13,723,008 | – | 274,900 | +100.0% | 0.48% | – |
| New | 2SEVENTY BIO INC | $13,581,040 | – | 1,342,000 | +100.0% | 0.47% | – | |
| Sell | MINERALYS THERAPEUTICS INC | $13,072,235 | -33.9% | 766,700 | -39.3% | 0.46% | -30.4% | |
| MRSN | Buy | MERSANA THERAPEUTICS INC | $12,469,100 | -11.6% | 3,790,000 | +10.4% | 0.44% | -6.8% |
| CARIBOU BIOSCIENCES INC | $11,724,050 | -20.0% | 2,758,600 | 0.0% | 0.41% | -15.8% | ||
| NSTG | Buy | NANOSTRING TECHNOLOGIES INC | $10,936,620 | -50.2% | 2,700,400 | +21.8% | 0.38% | -47.6% |
| ALPN | Buy | ALPINE IMMUNE SCIENCES INC | $10,881,380 | +42.4% | 1,058,500 | +7.0% | 0.38% | +49.6% |
| NARI | New | INARI MED INC | $10,174,500 | – | 175,000 | +100.0% | 0.36% | – |
| ETNB | Sell | 89BIO INC | $9,974,825 | -64.5% | 526,376 | -71.4% | 0.35% | -62.7% |
| ACIU | Buy | AC IMMUNE SA | $8,579,187 | +1026.7% | 2,903,278 | +792.2% | 0.30% | +1100.0% |
| DNLI | New | DENALI THERAPEUTICS INC | $8,344,012 | – | 282,752 | +100.0% | 0.29% | – |
| COLL | Sell | COLLEGIUM PHARMACEUTICAL INC | $7,609,609 | -17.7% | 354,100 | -8.1% | 0.27% | -13.4% |
| ATEC | New | ALPHATEC HLDGS INC | $7,066,140 | – | 393,000 | +100.0% | 0.25% | – |
| Sell | AN2 THERAPEUTICS INC | $5,586,200 | -21.7% | 657,200 | -9.1% | 0.20% | -17.7% | |
| GRTS | New | GRITSTONE BIO INC | $5,392,725 | – | 2,765,500 | +100.0% | 0.19% | – |
| CMPX | Sell | COMPASS THERAPEUTICS INC | $5,152,236 | -13.7% | 1,620,200 | -11.2% | 0.18% | -9.1% |
| SCYX | New | SCYNEXIS INC | $5,129,265 | – | 1,738,734 | +100.0% | 0.18% | – |
| Buy | SYROS PHARMACEUTICALS INC | $4,611,707 | +90.9% | 1,464,034 | +61.8% | 0.16% | +101.2% | |
| ALT | Sell | ALTIMMUNE INC | $4,144,573 | -25.3% | 1,174,100 | -10.7% | 0.14% | -21.2% |
| IPSC | Sell | CENTURY THERAPEUTICS INC | $3,510,444 | -20.2% | 1,110,900 | -12.4% | 0.12% | -15.8% |
| Sell | HYPERFINE INC | $2,554,583 | +18.0% | 1,188,178 | -21.0% | 0.09% | +23.6% | |
| SLP | New | SIMULATIONS PLUS INC | $1,988,847 | – | 45,900 | +100.0% | 0.07% | – |
| CMAX | Sell | CAREMAX INC | $1,977,960 | -1.9% | 636,000 | -15.8% | 0.07% | +3.0% |
| BHC | New | BAUSCH HEALTH COS INC | $1,720,800 | – | 215,100 | +100.0% | 0.06% | – |
| New | STRUCTURE THERAPEUTICS INCsponsored ads | $1,571,346 | – | 37,800 | +100.0% | 0.06% | – | |
| New | EXSCIENTIA PLCads | $755,392 | – | 127,600 | +100.0% | 0.03% | – | |
| New | ARTERIS INC | $514,910 | – | 75,500 | +100.0% | 0.02% | – | |
| NUVBWS | Sell | NUVATION BIO INC*w exp 07/07/202 | $14,978 | +24.8% | 90,560 | -9.4% | 0.00% | – |
| Exit | REUNION NEUROSCIENCE INC | $0 | – | -151,098 | -100.0% | -0.00% | – | |
| BCAB | Exit | BIOATLA INC | $0 | – | -602,500 | -100.0% | -0.05% | – |
| CYT | Exit | CYTEIR THERAPEUTICS INC | $0 | – | -1,764,100 | -100.0% | -0.11% | – |
| PRAX | Exit | PRAXIS PRECISION MEDICINES I | $0 | – | -4,281,700 | -100.0% | -0.12% | – |
| SGMO | Exit | SANGAMO THERAPEUTICS INC | $0 | – | -2,470,000 | -100.0% | -0.14% | – |
| GERN | Exit | GERON CORP | $0 | – | -2,128,000 | -100.0% | -0.15% | – |
| KNTE | Exit | KINNATE BIOPHARMA INC | $0 | – | -1,160,000 | -100.0% | -0.24% | – |
| CYTK | Exit | CYTOKINETICS INC | $0 | – | -252,000 | -100.0% | -0.29% | – |
| TWST | Exit | TWIST BIOSCIENCE CORP | $0 | – | -819,000 | -100.0% | -0.41% | – |
| BBIO | Exit | BRIDGEBIO PHARMA INC | $0 | – | -1,000,000 | -100.0% | -0.55% | – |
| DXCM | Exit | DEXCOM INC | $0 | – | -148,000 | -100.0% | -0.57% | – |
| ARQT | Exit | ARCUTIS BIOTHERAPEUTICS INC | $0 | – | -1,628,500 | -100.0% | -0.60% | – |
| RNA | Exit | AVIDITY BIOSCIENCES INC | $0 | – | -1,265,545 | -100.0% | -0.64% | – |
| AVTR | Exit | AVANTOR INC | $0 | – | -1,125,000 | -100.0% | -0.79% | – |
| BMRN | Exit | BIOMARIN PHARMACEUTICAL INC | $0 | – | -300,575 | -100.0% | -0.97% | – |
| ICLR | Exit | ICON PLC | $0 | – | -142,900 | -100.0% | -1.01% | – |
| BLU | Exit | BELLUS HEALTH INC NEW | $0 | – | -4,553,577 | -100.0% | -1.09% | – |
| ABT | Exit | ABBOTT LABS | $0 | – | -354,000 | -100.0% | -1.19% | – |
| ISEE | Exit | IVERIC BIO INC | $0 | – | -1,869,200 | -100.0% | -1.51% | – |
| MRK | Exit | MERCK & CO INC | $0 | – | -600,000 | -100.0% | -2.12% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC | 15 | Q3 2023 | 4.6% |
| ARVINAS INC | 14 | Q3 2023 | 4.9% |
| ZENTALIS PHARMACEUTICALS INC | 14 | Q3 2023 | 4.8% |
| SYNDAX PHARMACEUTICALS INC | 14 | Q3 2023 | 3.2% |
| IDEAYA BIOSCIENCES INC | 13 | Q3 2023 | 2.5% |
| NATERA INC | 13 | Q3 2023 | 1.9% |
| ALPINE IMMUNE SCIENCES INC | 13 | Q3 2023 | 0.5% |
| ABBVIE INC | 12 | Q2 2023 | 9.7% |
| HORIZON THERAPEUTICS PUB LTD | 12 | Q3 2022 | 3.4% |
| AVANTOR INC | 11 | Q1 2023 | 6.0% |
View Avidity Partners Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Adicet Bio, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| ALPINE IMMUNE SCIENCES, INC. | February 14, 2023 | 1,888,887 | 4.0% |
| ESSA Pharma Inc. | February 14, 2023 | 1,855,400 | 4.2% |
| Gritstone bio, Inc. | February 14, 2023 | 2,859,971 | 3.3% |
| IVERIC bio, Inc. | February 14, 2023 | 838,407 | 0.6% |
| ONCOSEC MEDICAL IncSold out | February 14, 2023 | 0 | 0.0% |
| PhaseBio Pharmaceuticals Inc | February 14, 2023 | 2,040,000 | 4.1% |
| Phathom Pharmaceuticals, Inc. | February 14, 2023 | 1,900,000 | 4.6% |
| Viridian Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Anika Therapeutics, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
View Avidity Partners Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-04-09 |
| SC 13G | 2024-03-27 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
View Avidity Partners Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.